Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion

IntroductionAntibodies targeting the blood-stage of Plasmodium falciparum play a critical role in naturally acquired immunity to malaria by limiting blood-stage parasitemia. One mode of action of antibodies is the direct inhibition of merozoite invasion of erythrocytes through targeting invasion lig...

Full description

Saved in:
Bibliographic Details
Main Authors: Linda Reiling, Kristina E. M. Persson, Fiona J. McCallum, Nimmo Gicheru, Samson M. Kinyanjui, Chetan E. Chitnis, Freya J. I. Fowkes, Kevin Marsh, James G. Beeson
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1532451/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849393284986699776
author Linda Reiling
Linda Reiling
Linda Reiling
Kristina E. M. Persson
Kristina E. M. Persson
Fiona J. McCallum
Nimmo Gicheru
Samson M. Kinyanjui
Chetan E. Chitnis
Freya J. I. Fowkes
Freya J. I. Fowkes
Freya J. I. Fowkes
Kevin Marsh
Kevin Marsh
James G. Beeson
James G. Beeson
James G. Beeson
James G. Beeson
author_facet Linda Reiling
Linda Reiling
Linda Reiling
Kristina E. M. Persson
Kristina E. M. Persson
Fiona J. McCallum
Nimmo Gicheru
Samson M. Kinyanjui
Chetan E. Chitnis
Freya J. I. Fowkes
Freya J. I. Fowkes
Freya J. I. Fowkes
Kevin Marsh
Kevin Marsh
James G. Beeson
James G. Beeson
James G. Beeson
James G. Beeson
author_sort Linda Reiling
collection DOAJ
description IntroductionAntibodies targeting the blood-stage of Plasmodium falciparum play a critical role in naturally acquired immunity to malaria by limiting blood-stage parasitemia. One mode of action of antibodies is the direct inhibition of merozoite invasion of erythrocytes through targeting invasion ligands. However, evasion of inhibitory antibodies may be mediated in P. falciparum by switching between various ligand-mediated merozoite invasion pathways. Here, we investigated the potential roles of invasion ligands PfRH1, PfRH2a and PfRH2b in immune evasion through phenotypic variation, and their importance as targets of human invasion-inhibitory antibodies.MethodsSerum samples from malaria-exposed children and adults in Kenya were examined for their ability to inhibit P. falciparum invasion, using parasites with disrupted pfrh1, pfrh2a or pfrh2b genes.Results and DiscussionThe loss of PfRH1 and PfRH2b substantially impacted on susceptibility to inhibitory antibodies, suggesting that variation in the use of these ligands contributes to immune evasion. The effect was less prominent with loss of PfRH2a. Differential inhibition of the knockout and parental lines points to PfRH1 and PfRH2b as targets of acquired growth inhibitory antibodies whereas PfRH2a appeared to be a minor target. There was limited relatedness of the inhibitory responses between different isolates or compared to parasites with deletions of erythrocyte-binding antigens. This further suggests that there is a substantial amount of antigenic diversity in invasion pathways to facilitate immune evasion. These findings provide evidence that PfRH1 and PfRH2b are significant targets of inhibitory antibodies and variation in their expression may facilitate immune evasion. Targeting of multiple invasion ligands in vaccine design is likely to be required to achieve potent inhibitory antibodies and protective efficacy against malaria.
format Article
id doaj-art-4d60ba3e19704b238769d67d953e254d
institution Kabale University
issn 1664-3224
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-4d60ba3e19704b238769d67d953e254d2025-08-20T03:40:28ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-03-011610.3389/fimmu.2025.15324511532451Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasionLinda Reiling0Linda Reiling1Linda Reiling2Kristina E. M. Persson3Kristina E. M. Persson4Fiona J. McCallum5Nimmo Gicheru6Samson M. Kinyanjui7Chetan E. Chitnis8Freya J. I. Fowkes9Freya J. I. Fowkes10Freya J. I. Fowkes11Kevin Marsh12Kevin Marsh13James G. Beeson14James G. Beeson15James G. Beeson16James G. Beeson17Department of Life Sciences, Burnet Institute of Medical Research and Public Health, Melbourne, VIC, AustraliaDepartment of Medicine, University of Melbourne, VIC, AustraliaDepartment of Immunology, Monash University, Melbourne, VIC, AustraliaDepartment of Laboratory Medicine, Lund University, Lund, SwedenClinical Chemistry and Pharmacology, Skåne University Hospital, Lund, SwedenAustralian Defence Force Malaria and Infectious Disease Institute, Enoggera, QLD, AustraliaCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, KenyaCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, KenyaDepartment of Parasites and Insect Vectors, Pasteur Institute, Paris, FranceDepartment of Life Sciences, Burnet Institute of Medical Research and Public Health, Melbourne, VIC, AustraliaCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia0Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, AustraliaCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, Kenya1Nuffield Department of Medicine, Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, United KingdomDepartment of Life Sciences, Burnet Institute of Medical Research and Public Health, Melbourne, VIC, Australia2Department of Microbiology, Monash University, Melbourne, VIC, Australia3School of Translational Medicine, Monash University, Melbourne, VIC, Australia4Department of Infectious Diseases, University of Melbourne, Melbourne, VIC, AustraliaIntroductionAntibodies targeting the blood-stage of Plasmodium falciparum play a critical role in naturally acquired immunity to malaria by limiting blood-stage parasitemia. One mode of action of antibodies is the direct inhibition of merozoite invasion of erythrocytes through targeting invasion ligands. However, evasion of inhibitory antibodies may be mediated in P. falciparum by switching between various ligand-mediated merozoite invasion pathways. Here, we investigated the potential roles of invasion ligands PfRH1, PfRH2a and PfRH2b in immune evasion through phenotypic variation, and their importance as targets of human invasion-inhibitory antibodies.MethodsSerum samples from malaria-exposed children and adults in Kenya were examined for their ability to inhibit P. falciparum invasion, using parasites with disrupted pfrh1, pfrh2a or pfrh2b genes.Results and DiscussionThe loss of PfRH1 and PfRH2b substantially impacted on susceptibility to inhibitory antibodies, suggesting that variation in the use of these ligands contributes to immune evasion. The effect was less prominent with loss of PfRH2a. Differential inhibition of the knockout and parental lines points to PfRH1 and PfRH2b as targets of acquired growth inhibitory antibodies whereas PfRH2a appeared to be a minor target. There was limited relatedness of the inhibitory responses between different isolates or compared to parasites with deletions of erythrocyte-binding antigens. This further suggests that there is a substantial amount of antigenic diversity in invasion pathways to facilitate immune evasion. These findings provide evidence that PfRH1 and PfRH2b are significant targets of inhibitory antibodies and variation in their expression may facilitate immune evasion. Targeting of multiple invasion ligands in vaccine design is likely to be required to achieve potent inhibitory antibodies and protective efficacy against malaria.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1532451/fullP. falciparuminhibitory antibodiesphenotypic variationimmune evasionreticulocyte binding homologuesRH proteins
spellingShingle Linda Reiling
Linda Reiling
Linda Reiling
Kristina E. M. Persson
Kristina E. M. Persson
Fiona J. McCallum
Nimmo Gicheru
Samson M. Kinyanjui
Chetan E. Chitnis
Freya J. I. Fowkes
Freya J. I. Fowkes
Freya J. I. Fowkes
Kevin Marsh
Kevin Marsh
James G. Beeson
James G. Beeson
James G. Beeson
James G. Beeson
Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion
Frontiers in Immunology
P. falciparum
inhibitory antibodies
phenotypic variation
immune evasion
reticulocyte binding homologues
RH proteins
title Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion
title_full Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion
title_fullStr Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion
title_full_unstemmed Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion
title_short Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion
title_sort plasmodium falciparum reticulocyte binding homologues are targets of human inhibitory antibodies and play a role in immune evasion
topic P. falciparum
inhibitory antibodies
phenotypic variation
immune evasion
reticulocyte binding homologues
RH proteins
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1532451/full
work_keys_str_mv AT lindareiling plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT lindareiling plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT lindareiling plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT kristinaempersson plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT kristinaempersson plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT fionajmccallum plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT nimmogicheru plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT samsonmkinyanjui plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT chetanechitnis plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT freyajifowkes plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT freyajifowkes plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT freyajifowkes plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT kevinmarsh plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT kevinmarsh plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT jamesgbeeson plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT jamesgbeeson plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT jamesgbeeson plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion
AT jamesgbeeson plasmodiumfalciparumreticulocytebindinghomologuesaretargetsofhumaninhibitoryantibodiesandplayaroleinimmuneevasion